Area of research
Immunology · Hematology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Immune Cell Function and Interaction, Immune cells in cancer, and CAR-T cell therapy research.
Classic Anti-Myeloma Treatments Alter Circulating Immune Cell Subsets with Potential Implications for T Cell Immunotherapies in Multiple Myeloma
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment
The Impact of Treatment-Free Intervals on T-Cell Exhaustion and Clonotypic Diversity in Myeloma Patients Treated with BCMA Bispecific Antibodies
Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs
Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell anti-metastatic function in the lung
Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion
CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3
Tumor pre-conditioning of draining lymph node stroma by lactic acid